| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 570 |
| 1 | RITUXIMAB | 557 |
| 2 | SERTRALINE HYDROCHLORIDE | 548 |
| 3 | ADALIMUMAB | 470 |
| 4 | TOCILIZUMAB | 465 |
| 5 | FOLIC ACID | 458 |
| 6 | DICLOFENAC SODIUM | 455 |
| 7 | DICLOFENAC | 447 |
| 8 | METHOTREXATE SODIUM | 447 |
| 9 | PREDNISONE | 437 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE BUTYRATE | 79 | 0.0400 |
| 1 | CAFFEINE CITRATE | 91 | 0.0390 |
| 2 | NEOMYCIN OINTMENT | 74 | 0.0302 |
| 3 | DICLOFENAC POTASSIUM TABLETS | 244 | 0.0281 |
| 4 | GOLIMUMAB | 337 | 0.0268 |
| 5 | HYDROCORTISONE SODIUM SUCCINATE | 96 | 0.0240 |
| 6 | DICLOFENAC POTASSIUM | 244 | 0.0221 |
| 7 | DESOGESTREL AND ETHINYL ESTRADIOL | 67 | 0.0204 |
| 8 | APREPITANT | 153 | 0.0203 |
| 9 | FLUOROMETHOLONE | 63 | 0.0193 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 744 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 680 |
| 2 | Corticosteroid [EPC] | 639 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 571 |
| 4 | Vitamin C [EPC] | 513 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 482 |
| 6 | Vitamin B12 [EPC] | 474 |
| 7 | Vitamin D [EPC] | 467 |
| 8 | Aminosalicylate [EPC] | 431 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 422 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 82 | 0.0443 |
| 1 | Interleukin-5 Antagonist [EPC] | 24 | 0.0349 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 153 | 0.0175 |
| 3 | Interleukin-17A Antagonist [EPC] | 416 | 0.0112 |
| 4 | Provitamin D2 Compound [EPC] | 240 | 0.0081 |
| 5 | CD19-directed Cytolytic Antibody [EPC] | 4 | 0.0047 |
| 6 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 18 | 0.0043 |
| 7 | Aminosalicylate [EPC] | 431 | 0.0043 |
| 8 | Methylxanthine [EPC] | 239 | 0.0041 |
| 9 | Oxytocic [EPC] | 12 | 0.0039 |